Department of Cardiology, Nicosia General Hospital, Nicosia, Cyprus.
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Curr Cardiol Rev. 2021;17(4):e230421189013. doi: 10.2174/1573403X16999201210195702.
Understanding the similarities and differences between myocardial infarction with or without ST-segment elevation is an essential step for proper patients' management in current practice. Both syndromes are caused by critical stenosis or total occlusion of coronary arteries (mostly due to thrombosis on atherosclerotic plaque), and manifest with a similar clinical presentation. Recent epidemiologic studies show that the relative incidence of ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) moves in an opposite fashion (decreasing and increasing respectively), with a prognosis that is worse at short-term follow-up for STEMI but comparable at long-term. Current management differs, as for STEMIs, immediate reperfusion is recommended, while for NSTEMIs, risk stratification is mandatory in order to stratify patients' risk, and then decide the timing for coronary angiography. Periprocedural and technical aspects of the interventional management, as well as antithrombotic medications, are for the most similarly implemented in the two types of MI, with routine radial access, DES implant, and novel P2Y12 inhibitors representing the standard of care in both cases. The following review article aims to compare the two types of MI, with and without persistent STsegment elevation. The main purpose is to explore their similarities and differences and address areas of uncertainty with regards to clinical presentation, therapeutic management, and prognosis. The identification of high-risk NSTEMI patients is important as they may require an individualised approach that can substantially overlap with current STEMI recommendations, and their mortality remains high if their management is delayed.
理解伴或不伴 ST 段抬高的心肌梗死之间的相似性和差异,是当前实践中对患者进行适当管理的重要步骤。这两种综合征都是由冠状动脉(主要是由于动脉粥样硬化斑块上的血栓)严重狭窄或完全闭塞引起的,临床表现相似。最近的流行病学研究表明,ST 段抬高型心肌梗死(STEMI)和非 ST 段抬高型心肌梗死(NSTEMI)的相对发病率呈相反趋势(分别减少和增加),STEMI 的短期随访预后较差,但长期预后相当。目前的管理方式有所不同,对于 STEMI,建议立即再灌注,而对于 NSTEMI,需要进行风险分层,以分层患者的风险,然后决定进行冠状动脉造影的时间。介入管理的围手术期和技术方面以及抗血栓药物,在这两种类型的 MI 中实施方式基本相同,常规桡动脉入路、DES 植入和新型 P2Y12 抑制剂是这两种情况下的标准治疗方法。本文旨在比较伴或不伴持续 ST 段抬高的两种类型的 MI,探讨其相似性和差异,并解决在临床表现、治疗管理和预后方面存在的不确定性问题。识别高危 NSTEMI 患者非常重要,因为他们可能需要个体化的治疗方法,这与目前 STEMI 的推荐方案有很大重叠,如果治疗延迟,他们的死亡率仍然很高。